上海地区早期肺癌、慢性阻塞性肺疾病和心血管疾病的CT筛查:基于人群的对比研究原理与设计
本研究为基于上海城市人群的对比研究,纳入10000名40至74岁无症状参与者,干预组按NELCIN-B3方案行低剂量胸部及心脏CT并在基线和1年后随访,对照组按常规CT方案及临床实践管理,比较两种肺结节管理方案的不必要转诊率,并评估CT影像生物标志物定量测量对肺癌、COPD和CVD早期检测的效果。
要点
- 干预组采用NELCIN-B3方案管理CT检出肺结节,对照组采用常规CT方案和临床实践管理。
- 研究比较NELCIN-B3方案与标准方案在早期检出肺结节管理中的不必要转诊率。
- 评估CT影像生物标志物定量测量对肺癌、COPD和CVD早期检测的效果。
核心结论
- 研究者预期CT影像生物标志物的定量评估将减少早期检出肺结节的不必要转诊,并改善中国城市人群COPD和CVD的早期检测。
研究设计与样本
- 基于人群的对比研究,纳入上海城市人群中40至74岁无症状参与者共10000名。
- 干预组在基线和1年后接受低剂量胸部及心脏CT扫描,并按NELCIN-B3方案管理。
- 对照组按常规CT方案接受低剂量胸部CT扫描,并按临床实践管理。
- 通过问卷收集流行病学数据,基线后第4年收集三种疾病的诊断。
- 试验注册号ClinicalTrials.gov NCT03988322,注册日期2019年6月14日。
诊断标准与关键数值
- 主要比较指标为NELCIN-B3方案与标准方案管理早期检出肺结节的不必要转诊率。
- 评估CT影像生物标志物定量测量对肺癌、COPD和CVD早期检测的效果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To describe the rational and design of a population-based comparative study. The objective of the study is to assess the screening performance of volume-based management of CT-detected lung nodule in comparison to diameter-based management, and to improve the effectiveness of CT screening for chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD), in addition to lung cancer, based on quantitative measurement of CT imaging biomarkers in a Chinese screening setting.
MATERIALS AND METHODS: A population-based comparative study is being performed, including 10,000 asymptomatic participants between 40 and 74 years old from Shanghai urban population. Participants in the intervention group undergo a low-dose chest and cardiac CT scan at baseline and 1 year later, and are managed according to NELCIN-B3 protocol. Participants in the control group undergo a low-dose chest CT scan according to the routine CT protocol and are managed according to the clinical practice. Epidemiological data are collected through questionnaires. In the fourth year from baseline, the diagnosis of the three diseases will be collected.
RESULTS: The unnecessary referral rate will be compared between NELCIN-B3 and standard protocol for managing early-detected lung nodules. The effectiveness of quantitative measurement of CT imaging biomarkers for early detection of lung cancer, COPD and CVD will be evaluated.
CONCLUSION: We expect that the quantitative assessment of the CT imaging biomarkers will reduce the number of unnecessary referrals for early detected lung nodules, and will improve the early detection of COPD and CVD in a Chinese urban population.
TRIAL REGISTRATION: ClinicalTrials.gov, NCT03988322. Registered on 14 June 2019.
引用
- Du Y, Li Q, Sidorenkov G, et al. Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai: Rationale and Design of a Population-based Comparative Study. Acad Radiol. 2020. PMID: 32151538. doi:10.1016/j.acra.2020.01.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。